Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Bednar

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonistsJ C Barrow, P G Nantermet, H G Selnick, et al.
Journal of Medicinal Chemistry|July 8, 1999
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregationM S Egbertson, J J Cook, B Bednar, et al.
Journal of Medicinal Chemistry|June 6, 1997
Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonistsB C Askew, R A Bednar, B Bednar, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonistsJ C Barrow, P G Nantermet, H G Selnick, et al.
Journal of Medicinal Chemistry|July 8, 1999
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregationM S Egbertson, J J Cook, B Bednar, et al.
Journal of Medicinal Chemistry|June 6, 1997
Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonistsB C Askew, R A Bednar, B Bednar, et al.
Pageof 3